Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (ανοίγει νέο παράθυρο)

Brady KM, Easley RB, Tobias JD.

Πηγή‎: Paediatr Anaesth 2006;16(10):1042-6.

Καταχώριση‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (ανοίγει νέο παράθυρο)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (ανοίγει νέο παράθυρο)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Πηγή‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Καταχώριση‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (ανοίγει νέο παράθυρο)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (ανοίγει νέο παράθυρο)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Πηγή‎: Pediatrics 2002;110(1 Pt 1):169-71.

Καταχώριση‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (ανοίγει νέο παράθυρο)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (ανοίγει νέο παράθυρο)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Πηγή‎: Paediatr Drugs 2017;19(1):53-8.

Καταχώριση‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (ανοίγει νέο παράθυρο)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (ανοίγει νέο παράθυρο)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Πηγή‎: J Perinatol 2011;31(3):188-92.

Καταχώριση‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (ανοίγει νέο παράθυρο)

Use of recombinant factor VIIa in infants with severe coagulopathy. (ανοίγει νέο παράθυρο)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Πηγή‎: J Perinatol 2004;24(5):310-1.

Καταχώριση‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (ανοίγει νέο παράθυρο)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (ανοίγει νέο παράθυρο)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Πηγή‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Καταχώριση‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (ανοίγει νέο παράθυρο)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (ανοίγει νέο παράθυρο)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Πηγή‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Καταχώριση‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (ανοίγει νέο παράθυρο)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (ανοίγει νέο παράθυρο)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Πηγή‎: Paediatr Anaesth 2009;19(4):364-70.

Καταχώριση‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (ανοίγει νέο παράθυρο)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (ανοίγει νέο παράθυρο)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Πηγή‎: Spine 2004;29(12):1384-7.

Καταχώριση‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (ανοίγει νέο παράθυρο)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (ανοίγει νέο παράθυρο)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Πηγή‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Καταχώριση‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (ανοίγει νέο παράθυρο)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (ανοίγει νέο παράθυρο)

Olomu N, Kulkarni R, Manco-Johnson M.

Πηγή‎: J Perinatol 2002;22(8):672-4.

Καταχώριση‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (ανοίγει νέο παράθυρο)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (ανοίγει νέο παράθυρο)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Πηγή‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Καταχώριση‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (ανοίγει νέο παράθυρο)